findmyKOL
Clinical trialNCT01382797CompletedPhase 2Interventional

ALK37-005: A Study of ALKS 37 (RDC-1036) in Adults With Opioid-induced Constipation (OIC)

SponsorAlkermes, Inc.Enrollment157Opioid-induced Constipation
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

20 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Alkermes Study Site

    Mesa, Arizona, United States

  • Alkermes Study Site

    Phoenix, Arizona, United States

  • Alkermes Study Site

    National City, California, United States

  • Alkermes Study Site

    Oceanside, California, United States

  • Alkermes Study Site

    Pasadena, California, United States

  • Alkermes Study Site

    Denver, Colorado, United States

  • Alkermes Investigational Site

    DeLand, Florida, United States

  • Alkermes Study Site

    Ormond Beach, Florida, United States

  • Alkermes Study Site

    St. Petersburg, Florida, United States

  • Alkermes Study Site

    Stockbridge, Georgia, United States

  • Alkermes Study Site

    Boise, Idaho, United States

  • Alkermes Study Site

    New Orleans, Louisiana, United States

  • Alkermes Study Site

    Kalamazoo, Michigan, United States

  • Alkermes Study Site

    Las Vegas, Nevada, United States

  • Alkermes Study Site

    Belvidere, New Jersey, United States

  • Alkermes Study Site

    Brooklyn, New York, United States

  • Alkermes Study Site

    Cincinnati, Ohio, United States

  • Alkermes Study Site

    Oklahoma City, Oklahoma, United States

  • Alkermes Study Site

    Medford, Oregon, United States

  • Alkermes Study Site

    San Antonio, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Aug 2011
Primary completion
30 Apr 2012
Completion
30 Apr 2012
Last update posted
13 Jun 2012
Registered enrollment
157
Registry id
NCT01382797

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.